No deviation Pte Ltd

No deviation Pte Ltd, based in Singapore, specializes in engineering consultancy and validation services for the pharmaceutical industry, ensuring compliance and operational efficiency for its clients. No deviation Pte Ltd, founded in 2007, focuses on delivering engineering consultancy, qualification, and validation services tailored for the pharmaceutical sector. The company operates from its headquarters in Singapore and has engaged in one significant deal to date. In March 2026, EFOR Consultants – SAS acquired No deviation Pte Ltd, strengthening its operations in Asia.

The founder's background includes experience in establishing other firms, although specific details are not disclosed. No deviation by Efor specializes in providing comprehensive engineering consultancy, commissioning, qualification, and validation services tailored for the pharmaceutical industry. The company’s core offerings facilitate regulatory compliance and enhance operational efficiency, focusing on achieving cGMP standards across various manufacturing units. Their services also include troubleshooting, continuous improvement initiatives, and tailored professional recruitment solutions to meet specific client needs.

By serving clients primarily in the Asia and European markets, No deviation ensures that pharmaceutical manufacturers are well-equipped to address compliance challenges while maintaining high-quality production standards. Their commitment to patient-centric solutions is reflected in the diverse clientele they support, which includes both established pharmaceutical companies and emerging biotech firms. Revenue generation for No deviation is driven by a combination of service contracts and professional recruitment partnerships within the pharmaceutical sector. Transactions typically involve B2B agreements where clients engage No deviation for ongoing support in areas like commissioning and regulatory compliance, often structured as project-based fees or retainer arrangements.

The firm may also implement subscription-based models for continuous consultancy services, ensuring that clients receive ongoing support tailored to their evolving regulatory needs. Additionally, the recruitment services provided are structured around placement fees based on a percentage of the hired candidate’s compensation, aligning incentives with client expectations. Overall, the company capitalizes on its extensive expertise to foster long-term relationships with clients, thereby driving a sustainable revenue model in the pharmaceutical consulting landscape. In March 2026, EFOR Consultants – SAS acquired No deviation Pte Ltd, aiming to accelerate its expansion in Asia by enhancing quality and compliance services for healthcare manufacturing clients in Singapore.

The acquisition is expected to support growth initiatives and bolster service offerings.